Trial
NCT02789397
Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
—
Condition
Granulomatous and Lymphocytic Interstitial Lung Disease
Intervention
Rituximab (RTX) and Azathioprine (AZA)
Why stopped
No funding for study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-10